MONTREAL, April 17, 2025 /PRNewswire/ -- On April 17, 2025, the global bleeding disorders community will come together under the theme "Access for all: Women and girls bleed too" and celebrate World Hemophilia Day. Today, women and girls with bleeding disorders (WGBDs) are still underdiagnosed and underserved. The global bleeding disorders community has the power—and the responsibility—to change this. Through recognition, diagnosis, treatment, and care, the quality of life of WGBDS will improve, and the bleeding disorders community will become stronger.
"Recognizing women and girls with bleeding disorders is a significant milestone for our community. In the past, they were often viewed solely as carriers rather than individuals with a bleeding disorder. It is time to fully embrace and acknowledge their experiences and struggles. Prioritizing the diagnosis and treatment of women and girls is crucial, and doing so strengthens our entire bleeding disorder community. Join us on April 17 to show your support for access for all—including women and girls."
—Cesar Garrido, WFH President
World Hemophilia Day 2025 is a call to action for governments, healthcare providers, and advocates worldwide to close the gaps in care for women and girls with bleeding disorders. These individuals often face delayed diagnoses, limited access to treatment, and a lack of understanding about their unique needs. By working together, we can challenge these inequities and ensure access to comprehensive care for everyone in the bleeding disorders community.
This year's theme highlights the importance of equity in healthcare, shining a light on the strength, resilience, and contributions of women and girls with bleeding disorders. Through global awareness efforts, we can break the stigma, improve education, and foster better outcomes for all.
World Hemophilia Day is an opportunity for individuals, organizations, and communities to come together and make a difference. Here are some ways to participate:
- Get social by posting about inherited bleeding disorders and raising awareness on women and girls with bleeding disorders on Facebook, Twitter, LinkedIn and Instagram using the #WorldHemophiliaDay, #WHD2025, #WeBleedToo and #LightItUpRed hashtags
- Support our global advocacy efforts and be a part of what we are building today for future generations by donating here
- Share your story on the WFH story site about how your quality of life—or the quality of life of someone you know—has changed thanks to receiving a diagnosis, treatment and care on wfh.org/whd
- Contact your national hemophilia and bleeding disorders association to find out how you and other members can work together on World Hemophilia Day and raise awareness about women and girls with bleeding disorders
- Download resources like posters and social media banners from wfh.org/whd to help build your World Hemophilia Day Campaign
- Send pictures, comments, or questions to the WFH at communications@wfh.org
Let's join hands on April 17, 2025, to ensure that women and girls with bleeding disorders are not left behind. Together, we can create a future where Treatment For All is a reality, and equity, care, and empowerment define the lives of those living with bleeding disorders.
To learn more about World Hemophilia Day, please visit wfh.org/world-hemophilia-day.
The WFH would like to thank our World Hemophilia Day sponsors for their continued support: Bayer, BioMarin Pharmaceutical Inc., Biotest, CSL Behring, F. Hoffman-La Roche Ltd., Grifols, Kedrion, LFB S.A, Novo Nordisk, Octapharma, Pfizer, Regeneron, Sanofi, Sobi, and Takeda.
About hemophilia and other bleeding disorders
In people with bleeding disorders, the blood clotting process doesn't work properly, with the result that they can bleed for longer than normal, and some people may experience spontaneous bleeding into joints, muscles, or other parts of their bodies which can lead to developmental and permanent mobility issues.
About the World Federation of Hemophilia
The World Federation of Hemophilia (WFH) is a non-profit organization dedicated to improving and sustaining care for people with inherited bleeding disorders around the world. At the WFH, national member organizations (NMOs) and health care professionals (HCPs) work together to provide care for people with inherited bleeding disorders around the world. We partner with governments and hemophilia treatment centres to enhance knowledge through training and provide tools they need to identify, support and treat people living with bleeding disorders in their communities, while promoting global advocacy and collaboration to achieve our common goals.
Our vision of Treatment for All is for a world where all people with inherited bleeding disorders have access to care, regardless of their type of bleeding disorder, gender, or where they live. Our mission is to improve and sustain care for people with inherited bleeding disorders around the world.
To find out more about the WFH, please visit www.wfh.org.
Media contact: Neha Suchak, Director, Marketing & Communications, nsuchak@wfh.org, +1 514-875-7944, #2857, www.wfh.org
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
World Hemophilia Day 2025 - April 17, 2025 - "Access for all: Women and girls bleed too"
|
YONGIN, South Korea, Jan. 14, 2026 /PRNewswire/ -- WIRobotics, a global robotics company co-led by Co-CEOs Younbaek Lee and Yongjae Kim, announced the successful conclusion of its participation at CES 2026, marking a shift from technology demonstration to the execution phase of global collaboration across both humanoid and wearable robotics.
Across CES 2026 Unveiled and the main exhibition, WIRobotics showcased its wearable walking-assist robot WIM S and humanoid robot ALLEX, moving beyond demonstrations to engage in concrete business discussions and technical collaboration planning. This year's CES served as a meaningful turning point, with tangible outcomes pointing toward real-world partnerships and business expansion.
At the exhibition, ALLEX attracted strong interest from global technology companies including NVIDIA, Meta, and Amazon, with purchase interest expressed by several organizations. WIRobotics also established concrete plans for technical collaboration and joint technology development with select AI big-tech companies, advancing discussions into an actionable stage.
ALLEX was highly regarded for its high-degree-of-freedom hands and arms, as well as its ability to deliver human-like force control and natural interaction across the full body. Strong anticipation was also shown for ALLEX's research-focused platform scheduled for commercial availability later this year, along with an expanded configuration integrated with a wheeled mobile base.
The company's wearable robot WIM also delivered tangible business outcomes at CES 2026. WIRobotics held discussions regarding potential collaboration with senior living communities and government-led programs in the United States, while advancing distribution partnerships in Mexico, the Middle East, and Southeast Asia, further solidifying its global expansion strategy.
With nearly three years of commercial deployment, WIM continues to demonstrate its value as a wearable robot designed for long-term daily use. Existing users from around the world visited the WIRobotics booth to experience product upgrades and share real-world usage feedback, reinforcing user trust and sustained adoption.
"CES 2026 marked a pivotal transition for WIRobotics—from presenting technology to executing real collaboration and business initiatives with global partners," said Younbaek Lee, Co-CEO of WIRobotics.
"The real-world experience and data accumulated through wearable robotics have become a core asset in accelerating the maturity and commercialization of our humanoid robotics technology. Building on both platforms, we will actively expand joint development and global market opportunities with our partners."
Following CES 2026, WIRobotics plans to accelerate global collaboration and business expansion centered on humanoid and wearable robotics, contributing to the broader integration of robotics across research, industry, and everyday life.
About WIRobotics
Founded in 2021, WIRobotics is a global robotics company spanning wearable robotics for everyday use and next-generation humanoid robotics. The company began commercial sales of lower-back and walking-assist wearable robots in 2023, and in the summer of 2025 unveiled the upper body of its humanoid robot, ALLEX, expanding into advanced humanoid robotics. By advancing both practical and cutting-edge robotic technologies, WIRobotics continues to shape the future of robotics on a global scale.
YONGIN, South Korea, Jan. 14, 2026 /PRNewswire/ -- WIRobotics, a global robotics company co-led by Co-CEOs Younbaek Lee and Yongjae Kim, announced the successful conclusion of its participation at CES 2026, marking a shift from technology demonstration to the execution phase of global collaboration across both humanoid and wearable robotics.
Across CES 2026 Unveiled and the main exhibition, WIRobotics showcased its wearable walking-assist robot WIM S and humanoid robot ALLEX, moving beyond demonstrations to engage in concrete business discussions and technical collaboration planning. This year's CES served as a meaningful turning point, with tangible outcomes pointing toward real-world partnerships and business expansion.
At the exhibition, ALLEX attracted strong interest from global technology companies including NVIDIA, Meta, and Amazon, with purchase interest expressed by several organizations. WIRobotics also established concrete plans for technical collaboration and joint technology development with select AI big-tech companies, advancing discussions into an actionable stage.
ALLEX was highly regarded for its high-degree-of-freedom hands and arms, as well as its ability to deliver human-like force control and natural interaction across the full body. Strong anticipation was also shown for ALLEX's research-focused platform scheduled for commercial availability later this year, along with an expanded configuration integrated with a wheeled mobile base.
The company's wearable robot WIM also delivered tangible business outcomes at CES 2026. WIRobotics held discussions regarding potential collaboration with senior living communities and government-led programs in the United States, while advancing distribution partnerships in Mexico, the Middle East, and Southeast Asia, further solidifying its global expansion strategy.
With nearly three years of commercial deployment, WIM continues to demonstrate its value as a wearable robot designed for long-term daily use. Existing users from around the world visited the WIRobotics booth to experience product upgrades and share real-world usage feedback, reinforcing user trust and sustained adoption.
"CES 2026 marked a pivotal transition for WIRobotics—from presenting technology to executing real collaboration and business initiatives with global partners," said Younbaek Lee, Co-CEO of WIRobotics.
"The real-world experience and data accumulated through wearable robotics have become a core asset in accelerating the maturity and commercialization of our humanoid robotics technology. Building on both platforms, we will actively expand joint development and global market opportunities with our partners."
Following CES 2026, WIRobotics plans to accelerate global collaboration and business expansion centered on humanoid and wearable robotics, contributing to the broader integration of robotics across research, industry, and everyday life.
About WIRobotics
Founded in 2021, WIRobotics is a global robotics company spanning wearable robotics for everyday use and next-generation humanoid robotics. The company began commercial sales of lower-back and walking-assist wearable robots in 2023, and in the summer of 2025 unveiled the upper body of its humanoid robot, ALLEX, expanding into advanced humanoid robotics. By advancing both practical and cutting-edge robotic technologies, WIRobotics continues to shape the future of robotics on a global scale.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
WIRobotics Concludes CES 2026, Advancing into Execution Phase of Global Collaboration Across Humanoid and Wearable Robotics
